Advertisement

pharmaceutical

MArS Supplier Spotlight

C T2023-11-15T18:52:14-05:00March 21st, 2022|Categories: Blog|Tags: Austria, Germay, health economics, market access, payers, pharmaceutical, podcast, pricing, reimbursement, Switzerland, tHEORetically Speaking, value communications|

Supplier Spotlight® highlights the unique skill sets and service offerings from organizations who are part of our CONNECTED COMMUNITY™. Below [...]

An Englishman in New York

C T2023-11-15T13:08:14-05:00November 29th, 2016|Categories: Blog, HEOR Feature|Tags: andrew briggs, health economics, health outcomes, HEOR, market access, pharmaceutical, pricing, tHEORetically Speaking|

Part I: A letter from America. by Professor Andrew Briggs "A cynic knows the price of everything but the [...]

Playing in the Real World Evidence Sandbox: Sharing, Teamwork, and Transparency

C T2023-11-15T17:45:22-05:00November 19th, 2014|Categories: Blog, HEOR Feature|Tags: Allan Korn, Blue Cross and Blue Shield, clinical research, FDAMA 114, HE-Xpo, health care, Healtheconomics.com, HEOR, HExpo_RWE, late phase research, market access, Nathan White, Patients, Patti Peeples, payers, pharmaceutical, pricing, real world evidence, RWE, tHEORetically Speaking, virtual conferences|

Is just playing in the same sandbox together an example of Real World Evidence (RWE) collaboration? Not really. So how [...]